Jane Street Group LLC lifted its position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 8.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,803 shares of the exchange traded fund’s stock after purchasing an additional 374 shares during the period. Jane Street Group LLC owned 0.35% of ProShares Ultra Nasdaq Biotechnology worth $306,000 at the end of the most recent quarter.
ProShares Ultra Nasdaq Biotechnology Stock Down 1.1 %
Shares of ProShares Ultra Nasdaq Biotechnology stock opened at $52.14 on Friday. ProShares Ultra Nasdaq Biotechnology has a 1 year low of $47.19 and a 1 year high of $69.56. The stock has a fifty day moving average price of $56.47 and a 200-day moving average price of $61.29.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 23rd were issued a dividend of $0.3964 per share. The ex-dividend date of this dividend was Monday, December 23rd. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.
ProShares Ultra Nasdaq Biotechnology Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
See Also
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- 3 REITs to Buy and Hold for the Long Term
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is Short Interest? How to Use It
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Airline Stocks – Top Airline Stocks to Buy Now
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report).
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
